HEPATOREN Trademark

Trademark Overview

On Friday, April 15, 2011, a trademark application was filed for HEPATOREN with the United States Patent and Trademark Office. The USPTO has given the HEPATOREN trademark a serial number of 85296570. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 9, 2022. This trademark is owned by Cumberland Pharmaceuticals Inc.. The HEPATOREN trademark is filed in the Pharmaceutical Products category with the following description:

a pharmaceutical preparation of thromboxane A2 receptor antagonist compound used to treat liver and kidney conditions in hospitalized patients
hepatoren

General Information

Serial Number85296570
Word MarkHEPATOREN
Filing DateFriday, April 15, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 9, 2022
Registration Number4106856
Registration DateTuesday, February 28, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2011

Trademark Statements

Goods and Servicesa pharmaceutical preparation of thromboxane A2 receptor antagonist compound used to treat liver and kidney conditions in hospitalized patients

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 9, 2022
Primary Code005
First Use Anywhere DateMonday, September 19, 2011
First Use In Commerce DateMonday, September 19, 2011

Trademark Owner History

Party NameCumberland Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Friday, September 9, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, February 28, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, February 13, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 13, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 13, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 29, 2018TEAS SECTION 8 & 15 RECEIVED
Tuesday, February 28, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 28, 2012REGISTERED-PRINCIPAL REGISTER
Friday, January 27, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 26, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, January 26, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 17, 2012STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 14, 2011USE AMENDMENT FILED
Tuesday, January 17, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 14, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, November 8, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2011PUBLISHED FOR OPPOSITION
Friday, August 5, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 5, 2011ASSIGNED TO LIE
Monday, July 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 25, 2011EXAMINER'S AMENDMENT ENTERED
Monday, July 25, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2011EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2011EXAMINERS AMENDMENT -WRITTEN
Thursday, July 21, 2011ASSIGNED TO EXAMINER
Tuesday, April 19, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 19, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

hepatoren kidney liver conditions hospitalized patients treat used thromboxane preparation receptor